Gifu, Japan

Masataka Okuno

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yasutoshi Muto. Active years: 1998.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masataka Okuno: Innovator in Anticarcinogenic Drug Composition

Introduction

Masataka Okuno is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of medicine, particularly in the development of anticarcinogenic drug compositions. His work aims to combat various forms of cancer, showcasing his dedication to improving health outcomes.

Latest Patents

Masataka Okuno holds a patent for an anticarcinogenic drug composition. This innovative composition effectively inhibits the recurrence of hepatocellular carcinoma and addresses the occurrence of other cancers, including cervical carcinoma intraepitheliale, lung adenocarcinoma, and mammary tumors. The composition is characterized by its high safety profile and contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof. He has 1 patent to his name.

Career Highlights

Throughout his career, Okuno has focused on developing solutions that target cancer prevention and treatment. His research has been instrumental in advancing the understanding of anticarcinogenic properties in drug compositions. His work reflects a commitment to addressing critical health challenges.

Collaborations

Masataka Okuno has collaborated with notable colleagues, including Yasutoshi Muto and Hisataka Moriwaki. These partnerships have contributed to the advancement of his research and the successful development of his patented drug composition.

Conclusion

Masataka Okuno's contributions to the field of anticarcinogenic drug development highlight his innovative spirit and dedication to improving cancer treatment. His work continues to inspire advancements in medical research and drug composition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…